drug development
Roche, Bristol Myers Squibb Partner on Digital Pathology Algorithms, Assays for Cancer Diagnosis
Under the collaboration, Roche is developing an artificial intelligence-based image analysis algorithm to help pathologists interpret its Ventana PD-L1 (SP142) Assay.
Genomenon, Inozyme Collaborate on MDx Effort for ENPP1 Deficiency
The companies hope to deliver AI-powered data to labs and clinicians to diagnose and treat a rare calcification disorder.
Thermo Fisher Scientific to Acquire Contract Research Organization PPD for $17.4B
Thermo Fisher will acquire PPD for $47.50 per share for a total price of $17.4 billion, plus the assumption of approximately $3.5 billion in debt.
AmoyDx, Premia Partner With Loxo on Genetic Testing for Cancer Therapy
AmoyDx and Premia will provide large-scale cancer patient screening in Asia to support Loxo-292 RET inhibitor clinical development.
Danaher Prices $2.76B Offering of Common, Preferred Stock
Danaher is offering 11 million shares of its common stock at $123 per share and 1.5 million shares of its mandatory convertible preferred stock at $1,000 per share.